Analystreport

Opiant Pharmaceuticals Inc (NASDAQ: OPNT) had its "buy" rating re-affirmed by analysts at Northland Securities.

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview